US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SDEV
$7.48
▲+0.00%
SPCX
$158.96
▲+0.00%
AMD
$633.91
▲+0.00%
TSLA
$370.59
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SDEV
$7.48
▲+0.00%
SPCX
$158.96
▲+0.00%
AMD
$633.91
▲+0.00%
TSLA
$370.59
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
(TSX:
BLCO
)
24.42
UNCHANGED
Delayed Quote
Updated: 3:59 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BLCO
< Previous
1
2
3
4
5
Next >
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser
September 11, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
September 02, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
September 01, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
August 24, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance
August 06, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance
July 29, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States
July 16, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
July 09, 2026
From
Bausch + Lomb
Via
Business Wire
Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
July 09, 2026
From
Bausch + Lomb
Via
Business Wire
Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
July 06, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence
July 01, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
June 01, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 21, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results
May 20, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States
May 19, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe
May 07, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Second R&D “Teach-in” Webinar
May 06, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting
April 30, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
April 29, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration
April 23, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Releases 2025 Sustainability Impact Report
April 22, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program
April 16, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
April 08, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe
April 07, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
April 06, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29
March 30, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
March 23, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches R&D “Teach-in” Webinar Series
March 09, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
February 24, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
February 18, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
< Previous
1
2
3
4
5
Next >
